CJC-1295 + Ipamorelin 10 MG

CJC-1295 + Ipamorelin is a multi-component peptide blend supplied for controlled laboratory, analytical, and scientific research.

Because the formulation contains two chemically distinct research peptides, the blend does not have one universal CAS number, molecular formula, molecular weight, or amino-acid sequence. Each component retains its own molecular identity and should be documented separately.

The exact identity of the CJC-1295 component must also be confirmed because commercial research products may contain either CJC-1295 with DAC or CJC-1295 without DAC / Modified GRF (1-29).

Component Overview

CJC-1295

CJC-1295 is a modified synthetic research peptide. Its molecular specifications depend on whether the supplied material contains the DAC modification.

For CJC-1295 with DAC, commonly referenced specifications include:

CAS #: 446262-90-4
Molecular Formula: C₁₆₅H₂₆₉N₄₇O₄₆
Molecular Weight: Approximately 3647.2 g/mol

A simple amino-acid sequence alone does not fully describe the DAC-containing form because the covalent modification forms part of the molecule’s complete chemical identity.

For CJC-1295 without DAC, the chemical identity and molecular specifications differ and should be documented according to the exact supplied material and Certificate of Analysis.

Ipamorelin

CAS #: 170851-70-4
Molecular Formula: C₃₈H₄₉N₉O₅
Molecular Weight: Approximately 711.85 g/mol
Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH₂
Length: 5 residues
Product Type: Modified Synthetic Research Pentapeptide

Ipamorelin contains non-standard and D-configured residues, making stereochemical and terminal information important to accurate analytical identification.

Research Applications

CJC-1295 + Ipamorelin may be examined in controlled non-clinical research involving:

• Multi-component peptide characterization
• Component identity verification
• Ligand-receptor interaction studies
• Molecular signaling research
• Comparative peptide analysis
• Structure-function studies
• Blend-ratio verification
• Stability assessment
• Non-clinical biochemical and cellular models

Experimental findings should remain specific to the applicable research system and should not be interpreted as evidence of hormonal benefit, performance enhancement, therapeutic effectiveness, or suitability for human use.

Analytical Identification

Relevant analytical characterization may include:

• CJC-1295 identity confirmation
• DAC-modification verification, where applicable
• Ipamorelin identity confirmation
• Modified-residue verification
• Molecular mass assessment
• Chromatographic purity testing
• Blend-ratio analysis
• Lot-specific quality testing

Specifications & Documentation

Lot-specific documentation should be reviewed for:

• Exact CJC-1295 form
• Exact Ipamorelin content
• Individual component quantities
• Total labeled content
• Molecular formulas
• Molecular weights
• Terminal and structural modifications
• Salt or counter-ion forms
• Purity specifications
• Analytical testing
• Lot or batch identification
• Certificate of Analysis
• Storage requirements

Authenticated product-specific documentation should take precedence over generalized blend information.

Storage & Handling

Store according to the conditions specified on the product label and Certificate of Analysis. Protect the material from environmental conditions that could compromise peptide integrity.

Handling should follow established laboratory procedures appropriate for multi-component research peptide materials.

Research Use Only

CJC-1295 + Ipamorelin is supplied exclusively for laboratory research, analytical testing, and scientific reference purposes.

Disclaimer

For research use only. Not for human or veterinary use. Not intended for consumption, administration, hormonal use, performance enhancement, diagnosis, treatment, mitigation, cure, or prevention of any disease. No therapeutic, hormonal, performance-related, medical, or clinical claims are made or implied. Product information is supplied solely for scientific identification, documentation, and research reference.